An overview on the potential roles of egcg in the treatment of covid-19 infection

Research output: Contribution to journalReview articlepeer-review


Coronavirus disease-19 (COVID-19) pandemic is currently ongoing worldwide and causes a lot of deaths in many countries. Although different vaccines for the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection have been developed and are now available, there are no effective antiviral drugs to treat the disease, except for Remdesivir authorized by the US FDA to counteract the emergency. Thus, it can be useful to find alternative therapies based on the employment of natural compounds, with antiviral features, to circumvent SARS-CoV-2 infection. Pre-clinical studies highlighted the antiviral activities of epigallocatechin-3-gallate (EGCG), a catechin primarily found in green tea, against various viruses, including SARS-CoV-2. In this review, we summarize this experi-mental evidence and highlight the potential use of EGCG as an alternative therapeutic choice for the treatment of SARS-CoV-2 infection.

Original languageEnglish
Pages (from-to)4447-4454
Number of pages8
JournalDrug Design, Development and Therapy
Publication statusPublished - 2021


  • Antiviral properties
  • COVID-19
  • EGCG
  • SARS-CoV-2
  • Tea polyphenols

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science
  • Drug Discovery


Dive into the research topics of 'An overview on the potential roles of egcg in the treatment of covid-19 infection'. Together they form a unique fingerprint.

Cite this